Photo Neuro-Modulation Therapy to Adults
Photo Neuro-Modulation Therapy, Mild Cognitive Impairment
About this trial
This is an interventional treatment trial for Photo Neuro-Modulation Therapy, Mild Cognitive Impairment
Eligibility Criteria
Inclusion Criteria:
- 40 middle age and older adults with aged 40 or above who have subjective memory complaints
Exclusion Criteria:
- A history of head injury, or any neurological/psychiatric disorders, and dementia will be excluded. In addition, a score higher than 7 on the short form of the Chinese Geriatric Depression Scale (CGDS-SF; Lee, Chiu, Kwok, & Leung, 1993)
Sites / Locations
- Neuropsychology Laboratory, Department of Psychology, The Chinese University of Hong KongRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Photoneuromodulation Therapy
Control Group
In this study low-level LED near-infrared (670-810nm) including MedX Health Model 1100 or WiseFori5-3800 will be used. The United States Food and Drug Administration (FDA) has approved this type of device as imposing insignificant risk (FDA-cleared for home treatment, 2005). At each visit, LED clusters will be applied simultaneously for 20 minutes on the Fp1, Fp2 and Pz regions according to the International 10-20 system (Homan, Herman and Purdy, 1987) (energy density, 13 Joules/cm2 [J/cm2] per each LED cluster head placement). The total LED treatment time per visit was 20 minutes.
Subject will not be given any active stimulation